Early left ventricular remodelling criteria and antihypertensive therapy effectiveness
https://doi.org/10.15829/1728-8800-2011-3-9-14
Abstract
Aim. To identify the criteria of early left ventricular (LV) remodelling; to assess the baseline structure and function of left and right cardiac chambers, as well as their dynamics during adequate antihypertensive therapy (AHT), in patients with Stage 2 arterial hypertension (AH).
Material and methods. In total, the study included 79 individuals: 35 patients with Stage 2 AH and 44 healthy volunteers. All participants underwent echocardiography (EchoCG), with the assessment of standard structural and functional remodelling parameters, as well as the original linear parameters “a”, “b”, and “c”, proposed by the authors. Twenty five AH patients were re-examined 1,5 years after the start of adequate AHT.
Results. Even early stages of AH are characterised by left and right ventricular dysfunction, as a manifestation of complex heart reaction to pressure overload. Simple, accessible EchoCG criteria, specifically, linear parameters of LV geometry “a”, “b”, and “c”, have been proposed to assess LV remodelling at earlier stages, compared to traditional parameters and spherical index. Adequate AHT resulted in improvement of left and right heart structure and function, with geometric parameters “a” and “b” being the most sensitive criteria.
Conclusion. In AH patients, the proposed linear parameters could be used as diagnostic criteria for earlyLV remodelling, as well as indicators of AHT effectiveness, considering their higher sensitivity, compared to traditional EchoCG parameters.
About the Authors
L. L. KirichenkoRussian Federation
Moscow
P. V. Struchkov
Russian Federation
Moscow
M. B. Poltanova
Russian Federation
Moscow
References
1. Диагностика и лечение артериальной гипертонии. Российские рекомендации (третий пересмотр). Приложение 2 к журналу Кардиоваскулярная терапия и профилактика 2008; 7 (6): 32с.
2. Кузнецова Л.М., Подчасов Д.А. Креативная эхокардиография: концепция оценки правых отделов сердца. Анналы РНЦХ РАМН 2005; выпуск 14: 66-9.
3. Оганов Р.О. Смертность от сердечно-сосудистых и других хронических неинфекционных заболеваний среди трудоспособного населения России. Кардиоваск тер профил 2002; 3: 4-8.
4. Преображенский Д..В., Сидоренко Б.А., Алехин М.Н. и др. Гипертрофия левого желудочка при гипертонической болезни. Часть II. Прогностическое значение гипертрофии левого желудочка. Кардиология 2003; 11: 98-101.
5. Руководство по артериальной гипертонии/Под редакцией академика Е.И. Чазова, профессора И.Е. Чазовой. Москва: Медиа Медика 2005; 784с.
6. Саидова М.А., Шитов В.Н., Чихладзе Н.М. и др. Методы ранней диагностики структурных и функциональных изменений миокарда у больных мягкой и умеренной артериальной гипертонией. Функц диагн 2007; 3: 33-40.
7. Чазова И.Е. Лечение АГ как профилактика сердечно-сосудистых осложнений. Ж серд недостат 2002; 1: 14-6.
8. Чазова И.Е. Образовательный Мастер-курс по артериальной гипертонии и сердечно-сосудистому риску. Кардиология 2008; 1: 77-8.
9. Casale PN, Devereux RB, Milner M, et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 2: 173-8.
10. Devereux RB, Wachtell K, Gerdts E, et al. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA 2004; 19: 2350-6.
11. Ganau A, Devereux RB, Roman MJ, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. JACC 1992; 7: 1550-8.
12. Harada K. Abnormal patterns of diurnal blood pressure variation and cardiovascular remodeling in elderly hypertensive patients. Nippon Ronen Igakkai Zasshi 2007; 4: 437-40.
13. Koren MJ, Devereux RB, Casale PN, et al. H. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 5: 345-52.
14. Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in Framingham Heart Study. N Engl J Med 1990; 22: 1561-6.
15. Muiesan ML, Salvetti M, Paini A, et al. Inappropriate left ventricular mass changes during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension 2007; 5: 1077-83.
16. Recommendations for chamber quantification: A report from American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber quantification writing group, developed in conjunction with European Association of Echocardiography, a branch of European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1146-447.
17. The Task Force for the management of arterial hypertension of the European Society of Hypertension and of the European Society of Cardiology.2007 Guidelines for the management of arterial hypertension. J Hypertens 2007; 25: 1105-87.
Review
For citations:
Kirichenko L.L., Struchkov P.V., Poltanova M.B. Early left ventricular remodelling criteria and antihypertensive therapy effectiveness. Cardiovascular Therapy and Prevention. 2011;10(3):9-14. (In Russ.) https://doi.org/10.15829/1728-8800-2011-3-9-14